Global Alpha-1 Lung Disease Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Alpha-1 antitrypsin deficiency (A1AD) is a hereditary disorder characterized by low levels of a protein called alpha-1 antitrypsin (A1AT) which is found in the blood. This deficiency may predispose an individual to several illnesses and most commonly manifests as chronic obstructive pulmonary disease (including bronchiectasis) and liver disease (especially cirrhosis and hepatoma), or more rarely, as a skin condition called panniculitis. A1AD is also more frequent among individuals with Wegener’s granulomatosis, now called polyangiitis with granulomatosis. A deficiency of A1AT allows substances that break down proteins (so-called proteolytic enzymes) to attack various tissues of the body. The attack results in destructive changes in the lungs (emphysema) and may also affect the liver and skin. Alpha-1 antitrypsin is ordinarily released by specialized, granules within a type of white blood cells (called neutrophils or polymorphonuclear leukocytes) in response to infection or inflammation. Deficiency of alpha-1 antitrypsin results in unbalanced (i.e., relatively unopposed) rapid breakdown of proteins (protease activity), especially in the supporting elastic structures of the lungs. Over years, this destruction can lead to progressive emphysema and is accelerated by smoking, some occupational exposures, and likely by other genetic modifiers of this risk which remain incompletely understood.
LPI (LP Information)' newest research report, the “Alpha-1 Lung Disease Industry Forecast” looks at past sales and reviews total world Alpha-1 Lung Disease sales in 2022, providing a comprehensive analysis by region and market sector of projected Alpha-1 Lung Disease sales for 2023 through 2029. With Alpha-1 Lung Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alpha-1 Lung Disease industry.
This Insight Report provides a comprehensive analysis of the global Alpha-1 Lung Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alpha-1 Lung Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alpha-1 Lung Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alpha-1 Lung Disease and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alpha-1 Lung Disease.
The global Alpha-1 Lung Disease market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Alpha-1 Lung Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Alpha-1 Lung Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Alpha-1 Lung Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Alpha-1 Lung Disease players cover Pfizer, Baxter, AstraZeneca, Grifols, Teva Pharmaceutical Industries, Boehringer Ingelheim, Kamada Ltd, GlaxoSmithKline and CSL Behring, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Alpha-1 Lung Disease market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Alpha-1 antitrypsin deficiency (A1AD) is a hereditary disorder characterized by low levels of a protein called alpha-1 antitrypsin (A1AT) which is found in the blood. This deficiency may predispose an individual to several illnesses and most commonly manifests as chronic obstructive pulmonary disease (including bronchiectasis) and liver disease (especially cirrhosis and hepatoma), or more rarely, as a skin condition called panniculitis. A1AD is also more frequent among individuals with Wegener’s granulomatosis, now called polyangiitis with granulomatosis. A deficiency of A1AT allows substances that break down proteins (so-called proteolytic enzymes) to attack various tissues of the body. The attack results in destructive changes in the lungs (emphysema) and may also affect the liver and skin. Alpha-1 antitrypsin is ordinarily released by specialized, granules within a type of white blood cells (called neutrophils or polymorphonuclear leukocytes) in response to infection or inflammation. Deficiency of alpha-1 antitrypsin results in unbalanced (i.e., relatively unopposed) rapid breakdown of proteins (protease activity), especially in the supporting elastic structures of the lungs. Over years, this destruction can lead to progressive emphysema and is accelerated by smoking, some occupational exposures, and likely by other genetic modifiers of this risk which remain incompletely understood.
LPI (LP Information)' newest research report, the “Alpha-1 Lung Disease Industry Forecast” looks at past sales and reviews total world Alpha-1 Lung Disease sales in 2022, providing a comprehensive analysis by region and market sector of projected Alpha-1 Lung Disease sales for 2023 through 2029. With Alpha-1 Lung Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alpha-1 Lung Disease industry.
This Insight Report provides a comprehensive analysis of the global Alpha-1 Lung Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alpha-1 Lung Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alpha-1 Lung Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alpha-1 Lung Disease and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alpha-1 Lung Disease.
The global Alpha-1 Lung Disease market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Alpha-1 Lung Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Alpha-1 Lung Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Alpha-1 Lung Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Alpha-1 Lung Disease players cover Pfizer, Baxter, AstraZeneca, Grifols, Teva Pharmaceutical Industries, Boehringer Ingelheim, Kamada Ltd, GlaxoSmithKline and CSL Behring, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Alpha-1 Lung Disease market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Augmentation Therapy
- Cystic Fibrosis(CF)
- Non-CF Bronchiectasis(NCFB)
- Other
- Hospitals
- Specialty Clinics
- Pharmacies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Baxter
- AstraZeneca
- Grifols
- Teva Pharmaceutical Industries
- Boehringer Ingelheim
- Kamada Ltd
- GlaxoSmithKline
- CSL Behring
- Takeda
- LFB Biomedicaments
- Abeona Therapeutics
- Biogen
- Vertex Pharmaceuticals
- Baxalta
- Arrowhead Research Corporation
- ProBioGen
- Chiesi Pharmaceuticals
- Kedrion Group
- ProMetic Life Sciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alpha-1 Lung Disease Market Size 2018-2029
2.1.2 Alpha-1 Lung Disease Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Alpha-1 Lung Disease Segment by Type
2.2.1 Augmentation Therapy
2.2.2 Cystic Fibrosis(CF)
2.2.3 Non-CF Bronchiectasis(NCFB)
2.2.4 Other
2.3 Alpha-1 Lung Disease Market Size by Type
2.3.1 Alpha-1 Lung Disease Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
2.4 Alpha-1 Lung Disease Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Pharmacies
2.4.4 Others
2.5 Alpha-1 Lung Disease Market Size by Application
2.5.1 Alpha-1 Lung Disease Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
3 ALPHA-1 LUNG DISEASE MARKET SIZE BY PLAYER
3.1 Alpha-1 Lung Disease Market Size Market Share by Players
3.1.1 Global Alpha-1 Lung Disease Revenue by Players (2018-2023)
3.1.2 Global Alpha-1 Lung Disease Revenue Market Share by Players (2018-2023)
3.2 Global Alpha-1 Lung Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ALPHA-1 LUNG DISEASE BY REGIONS
4.1 Alpha-1 Lung Disease Market Size by Regions (2018-2023)
4.2 Americas Alpha-1 Lung Disease Market Size Growth (2018-2023)
4.3 APAC Alpha-1 Lung Disease Market Size Growth (2018-2023)
4.4 Europe Alpha-1 Lung Disease Market Size Growth (2018-2023)
4.5 Middle East & Africa Alpha-1 Lung Disease Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Alpha-1 Lung Disease Market Size by Country (2018-2023)
5.2 Americas Alpha-1 Lung Disease Market Size by Type (2018-2023)
5.3 Americas Alpha-1 Lung Disease Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alpha-1 Lung Disease Market Size by Region (2018-2023)
6.2 APAC Alpha-1 Lung Disease Market Size by Type (2018-2023)
6.3 APAC Alpha-1 Lung Disease Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Alpha-1 Lung Disease by Country (2018-2023)
7.2 Europe Alpha-1 Lung Disease Market Size by Type (2018-2023)
7.3 Europe Alpha-1 Lung Disease Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alpha-1 Lung Disease by Region (2018-2023)
8.2 Middle East & Africa Alpha-1 Lung Disease Market Size by Type (2018-2023)
8.3 Middle East & Africa Alpha-1 Lung Disease Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ALPHA-1 LUNG DISEASE MARKET FORECAST
10.1 Global Alpha-1 Lung Disease Forecast by Regions (2024-2029)
10.1.1 Global Alpha-1 Lung Disease Forecast by Regions (2024-2029)
10.1.2 Americas Alpha-1 Lung Disease Forecast
10.1.3 APAC Alpha-1 Lung Disease Forecast
10.1.4 Europe Alpha-1 Lung Disease Forecast
10.1.5 Middle East & Africa Alpha-1 Lung Disease Forecast
10.2 Americas Alpha-1 Lung Disease Forecast by Country (2024-2029)
10.2.1 United States Alpha-1 Lung Disease Market Forecast
10.2.2 Canada Alpha-1 Lung Disease Market Forecast
10.2.3 Mexico Alpha-1 Lung Disease Market Forecast
10.2.4 Brazil Alpha-1 Lung Disease Market Forecast
10.3 APAC Alpha-1 Lung Disease Forecast by Region (2024-2029)
10.3.1 China Alpha-1 Lung Disease Market Forecast
10.3.2 Japan Alpha-1 Lung Disease Market Forecast
10.3.3 Korea Alpha-1 Lung Disease Market Forecast
10.3.4 Southeast Asia Alpha-1 Lung Disease Market Forecast
10.3.5 India Alpha-1 Lung Disease Market Forecast
10.3.6 Australia Alpha-1 Lung Disease Market Forecast
10.4 Europe Alpha-1 Lung Disease Forecast by Country (2024-2029)
10.4.1 Germany Alpha-1 Lung Disease Market Forecast
10.4.2 France Alpha-1 Lung Disease Market Forecast
10.4.3 UK Alpha-1 Lung Disease Market Forecast
10.4.4 Italy Alpha-1 Lung Disease Market Forecast
10.4.5 Russia Alpha-1 Lung Disease Market Forecast
10.5 Middle East & Africa Alpha-1 Lung Disease Forecast by Region (2024-2029)
10.5.1 Egypt Alpha-1 Lung Disease Market Forecast
10.5.2 South Africa Alpha-1 Lung Disease Market Forecast
10.5.3 Israel Alpha-1 Lung Disease Market Forecast
10.5.4 Turkey Alpha-1 Lung Disease Market Forecast
10.5.5 GCC Countries Alpha-1 Lung Disease Market Forecast
10.6 Global Alpha-1 Lung Disease Forecast by Type (2024-2029)
10.7 Global Alpha-1 Lung Disease Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Alpha-1 Lung Disease Product Offered
11.1.3 Pfizer Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Baxter
11.2.1 Baxter Company Information
11.2.2 Baxter Alpha-1 Lung Disease Product Offered
11.2.3 Baxter Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Baxter Main Business Overview
11.2.5 Baxter Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Alpha-1 Lung Disease Product Offered
11.3.3 AstraZeneca Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Grifols
11.4.1 Grifols Company Information
11.4.2 Grifols Alpha-1 Lung Disease Product Offered
11.4.3 Grifols Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Grifols Main Business Overview
11.4.5 Grifols Latest Developments
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Information
11.5.2 Teva Pharmaceutical Industries Alpha-1 Lung Disease Product Offered
11.5.3 Teva Pharmaceutical Industries Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Teva Pharmaceutical Industries Main Business Overview
11.5.5 Teva Pharmaceutical Industries Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Alpha-1 Lung Disease Product Offered
11.6.3 Boehringer Ingelheim Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 Kamada Ltd
11.7.1 Kamada Ltd Company Information
11.7.2 Kamada Ltd Alpha-1 Lung Disease Product Offered
11.7.3 Kamada Ltd Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Kamada Ltd Main Business Overview
11.7.5 Kamada Ltd Latest Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Alpha-1 Lung Disease Product Offered
11.8.3 GlaxoSmithKline Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 GlaxoSmithKline Main Business Overview
11.8.5 GlaxoSmithKline Latest Developments
11.9 CSL Behring
11.9.1 CSL Behring Company Information
11.9.2 CSL Behring Alpha-1 Lung Disease Product Offered
11.9.3 CSL Behring Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 CSL Behring Main Business Overview
11.9.5 CSL Behring Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Alpha-1 Lung Disease Product Offered
11.10.3 Takeda Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 LFB Biomedicaments
11.11.1 LFB Biomedicaments Company Information
11.11.2 LFB Biomedicaments Alpha-1 Lung Disease Product Offered
11.11.3 LFB Biomedicaments Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 LFB Biomedicaments Main Business Overview
11.11.5 LFB Biomedicaments Latest Developments
11.12 Abeona Therapeutics
11.12.1 Abeona Therapeutics Company Information
11.12.2 Abeona Therapeutics Alpha-1 Lung Disease Product Offered
11.12.3 Abeona Therapeutics Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Abeona Therapeutics Main Business Overview
11.12.5 Abeona Therapeutics Latest Developments
11.13 Biogen
11.13.1 Biogen Company Information
11.13.2 Biogen Alpha-1 Lung Disease Product Offered
11.13.3 Biogen Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Biogen Main Business Overview
11.13.5 Biogen Latest Developments
11.14 Vertex Pharmaceuticals
11.14.1 Vertex Pharmaceuticals Company Information
11.14.2 Vertex Pharmaceuticals Alpha-1 Lung Disease Product Offered
11.14.3 Vertex Pharmaceuticals Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Vertex Pharmaceuticals Main Business Overview
11.14.5 Vertex Pharmaceuticals Latest Developments
11.15 Baxalta
11.15.1 Baxalta Company Information
11.15.2 Baxalta Alpha-1 Lung Disease Product Offered
11.15.3 Baxalta Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Baxalta Main Business Overview
11.15.5 Baxalta Latest Developments
11.16 Arrowhead Research Corporation
11.16.1 Arrowhead Research Corporation Company Information
11.16.2 Arrowhead Research Corporation Alpha-1 Lung Disease Product Offered
11.16.3 Arrowhead Research Corporation Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Arrowhead Research Corporation Main Business Overview
11.16.5 Arrowhead Research Corporation Latest Developments
11.17 ProBioGen
11.17.1 ProBioGen Company Information
11.17.2 ProBioGen Alpha-1 Lung Disease Product Offered
11.17.3 ProBioGen Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 ProBioGen Main Business Overview
11.17.5 ProBioGen Latest Developments
11.18 Chiesi Pharmaceuticals
11.18.1 Chiesi Pharmaceuticals Company Information
11.18.2 Chiesi Pharmaceuticals Alpha-1 Lung Disease Product Offered
11.18.3 Chiesi Pharmaceuticals Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Chiesi Pharmaceuticals Main Business Overview
11.18.5 Chiesi Pharmaceuticals Latest Developments
11.19 Kedrion Group
11.19.1 Kedrion Group Company Information
11.19.2 Kedrion Group Alpha-1 Lung Disease Product Offered
11.19.3 Kedrion Group Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Kedrion Group Main Business Overview
11.19.5 Kedrion Group Latest Developments
11.20 ProMetic Life Sciences
11.20.1 ProMetic Life Sciences Company Information
11.20.2 ProMetic Life Sciences Alpha-1 Lung Disease Product Offered
11.20.3 ProMetic Life Sciences Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 ProMetic Life Sciences Main Business Overview
11.20.5 ProMetic Life Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alpha-1 Lung Disease Market Size 2018-2029
2.1.2 Alpha-1 Lung Disease Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Alpha-1 Lung Disease Segment by Type
2.2.1 Augmentation Therapy
2.2.2 Cystic Fibrosis(CF)
2.2.3 Non-CF Bronchiectasis(NCFB)
2.2.4 Other
2.3 Alpha-1 Lung Disease Market Size by Type
2.3.1 Alpha-1 Lung Disease Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
2.4 Alpha-1 Lung Disease Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Pharmacies
2.4.4 Others
2.5 Alpha-1 Lung Disease Market Size by Application
2.5.1 Alpha-1 Lung Disease Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
3 ALPHA-1 LUNG DISEASE MARKET SIZE BY PLAYER
3.1 Alpha-1 Lung Disease Market Size Market Share by Players
3.1.1 Global Alpha-1 Lung Disease Revenue by Players (2018-2023)
3.1.2 Global Alpha-1 Lung Disease Revenue Market Share by Players (2018-2023)
3.2 Global Alpha-1 Lung Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ALPHA-1 LUNG DISEASE BY REGIONS
4.1 Alpha-1 Lung Disease Market Size by Regions (2018-2023)
4.2 Americas Alpha-1 Lung Disease Market Size Growth (2018-2023)
4.3 APAC Alpha-1 Lung Disease Market Size Growth (2018-2023)
4.4 Europe Alpha-1 Lung Disease Market Size Growth (2018-2023)
4.5 Middle East & Africa Alpha-1 Lung Disease Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Alpha-1 Lung Disease Market Size by Country (2018-2023)
5.2 Americas Alpha-1 Lung Disease Market Size by Type (2018-2023)
5.3 Americas Alpha-1 Lung Disease Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alpha-1 Lung Disease Market Size by Region (2018-2023)
6.2 APAC Alpha-1 Lung Disease Market Size by Type (2018-2023)
6.3 APAC Alpha-1 Lung Disease Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Alpha-1 Lung Disease by Country (2018-2023)
7.2 Europe Alpha-1 Lung Disease Market Size by Type (2018-2023)
7.3 Europe Alpha-1 Lung Disease Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alpha-1 Lung Disease by Region (2018-2023)
8.2 Middle East & Africa Alpha-1 Lung Disease Market Size by Type (2018-2023)
8.3 Middle East & Africa Alpha-1 Lung Disease Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ALPHA-1 LUNG DISEASE MARKET FORECAST
10.1 Global Alpha-1 Lung Disease Forecast by Regions (2024-2029)
10.1.1 Global Alpha-1 Lung Disease Forecast by Regions (2024-2029)
10.1.2 Americas Alpha-1 Lung Disease Forecast
10.1.3 APAC Alpha-1 Lung Disease Forecast
10.1.4 Europe Alpha-1 Lung Disease Forecast
10.1.5 Middle East & Africa Alpha-1 Lung Disease Forecast
10.2 Americas Alpha-1 Lung Disease Forecast by Country (2024-2029)
10.2.1 United States Alpha-1 Lung Disease Market Forecast
10.2.2 Canada Alpha-1 Lung Disease Market Forecast
10.2.3 Mexico Alpha-1 Lung Disease Market Forecast
10.2.4 Brazil Alpha-1 Lung Disease Market Forecast
10.3 APAC Alpha-1 Lung Disease Forecast by Region (2024-2029)
10.3.1 China Alpha-1 Lung Disease Market Forecast
10.3.2 Japan Alpha-1 Lung Disease Market Forecast
10.3.3 Korea Alpha-1 Lung Disease Market Forecast
10.3.4 Southeast Asia Alpha-1 Lung Disease Market Forecast
10.3.5 India Alpha-1 Lung Disease Market Forecast
10.3.6 Australia Alpha-1 Lung Disease Market Forecast
10.4 Europe Alpha-1 Lung Disease Forecast by Country (2024-2029)
10.4.1 Germany Alpha-1 Lung Disease Market Forecast
10.4.2 France Alpha-1 Lung Disease Market Forecast
10.4.3 UK Alpha-1 Lung Disease Market Forecast
10.4.4 Italy Alpha-1 Lung Disease Market Forecast
10.4.5 Russia Alpha-1 Lung Disease Market Forecast
10.5 Middle East & Africa Alpha-1 Lung Disease Forecast by Region (2024-2029)
10.5.1 Egypt Alpha-1 Lung Disease Market Forecast
10.5.2 South Africa Alpha-1 Lung Disease Market Forecast
10.5.3 Israel Alpha-1 Lung Disease Market Forecast
10.5.4 Turkey Alpha-1 Lung Disease Market Forecast
10.5.5 GCC Countries Alpha-1 Lung Disease Market Forecast
10.6 Global Alpha-1 Lung Disease Forecast by Type (2024-2029)
10.7 Global Alpha-1 Lung Disease Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Alpha-1 Lung Disease Product Offered
11.1.3 Pfizer Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Baxter
11.2.1 Baxter Company Information
11.2.2 Baxter Alpha-1 Lung Disease Product Offered
11.2.3 Baxter Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Baxter Main Business Overview
11.2.5 Baxter Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Alpha-1 Lung Disease Product Offered
11.3.3 AstraZeneca Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Grifols
11.4.1 Grifols Company Information
11.4.2 Grifols Alpha-1 Lung Disease Product Offered
11.4.3 Grifols Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Grifols Main Business Overview
11.4.5 Grifols Latest Developments
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Information
11.5.2 Teva Pharmaceutical Industries Alpha-1 Lung Disease Product Offered
11.5.3 Teva Pharmaceutical Industries Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Teva Pharmaceutical Industries Main Business Overview
11.5.5 Teva Pharmaceutical Industries Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Alpha-1 Lung Disease Product Offered
11.6.3 Boehringer Ingelheim Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 Kamada Ltd
11.7.1 Kamada Ltd Company Information
11.7.2 Kamada Ltd Alpha-1 Lung Disease Product Offered
11.7.3 Kamada Ltd Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Kamada Ltd Main Business Overview
11.7.5 Kamada Ltd Latest Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Alpha-1 Lung Disease Product Offered
11.8.3 GlaxoSmithKline Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 GlaxoSmithKline Main Business Overview
11.8.5 GlaxoSmithKline Latest Developments
11.9 CSL Behring
11.9.1 CSL Behring Company Information
11.9.2 CSL Behring Alpha-1 Lung Disease Product Offered
11.9.3 CSL Behring Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 CSL Behring Main Business Overview
11.9.5 CSL Behring Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Alpha-1 Lung Disease Product Offered
11.10.3 Takeda Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 LFB Biomedicaments
11.11.1 LFB Biomedicaments Company Information
11.11.2 LFB Biomedicaments Alpha-1 Lung Disease Product Offered
11.11.3 LFB Biomedicaments Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 LFB Biomedicaments Main Business Overview
11.11.5 LFB Biomedicaments Latest Developments
11.12 Abeona Therapeutics
11.12.1 Abeona Therapeutics Company Information
11.12.2 Abeona Therapeutics Alpha-1 Lung Disease Product Offered
11.12.3 Abeona Therapeutics Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Abeona Therapeutics Main Business Overview
11.12.5 Abeona Therapeutics Latest Developments
11.13 Biogen
11.13.1 Biogen Company Information
11.13.2 Biogen Alpha-1 Lung Disease Product Offered
11.13.3 Biogen Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Biogen Main Business Overview
11.13.5 Biogen Latest Developments
11.14 Vertex Pharmaceuticals
11.14.1 Vertex Pharmaceuticals Company Information
11.14.2 Vertex Pharmaceuticals Alpha-1 Lung Disease Product Offered
11.14.3 Vertex Pharmaceuticals Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Vertex Pharmaceuticals Main Business Overview
11.14.5 Vertex Pharmaceuticals Latest Developments
11.15 Baxalta
11.15.1 Baxalta Company Information
11.15.2 Baxalta Alpha-1 Lung Disease Product Offered
11.15.3 Baxalta Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Baxalta Main Business Overview
11.15.5 Baxalta Latest Developments
11.16 Arrowhead Research Corporation
11.16.1 Arrowhead Research Corporation Company Information
11.16.2 Arrowhead Research Corporation Alpha-1 Lung Disease Product Offered
11.16.3 Arrowhead Research Corporation Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Arrowhead Research Corporation Main Business Overview
11.16.5 Arrowhead Research Corporation Latest Developments
11.17 ProBioGen
11.17.1 ProBioGen Company Information
11.17.2 ProBioGen Alpha-1 Lung Disease Product Offered
11.17.3 ProBioGen Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 ProBioGen Main Business Overview
11.17.5 ProBioGen Latest Developments
11.18 Chiesi Pharmaceuticals
11.18.1 Chiesi Pharmaceuticals Company Information
11.18.2 Chiesi Pharmaceuticals Alpha-1 Lung Disease Product Offered
11.18.3 Chiesi Pharmaceuticals Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Chiesi Pharmaceuticals Main Business Overview
11.18.5 Chiesi Pharmaceuticals Latest Developments
11.19 Kedrion Group
11.19.1 Kedrion Group Company Information
11.19.2 Kedrion Group Alpha-1 Lung Disease Product Offered
11.19.3 Kedrion Group Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Kedrion Group Main Business Overview
11.19.5 Kedrion Group Latest Developments
11.20 ProMetic Life Sciences
11.20.1 ProMetic Life Sciences Company Information
11.20.2 ProMetic Life Sciences Alpha-1 Lung Disease Product Offered
11.20.3 ProMetic Life Sciences Alpha-1 Lung Disease Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 ProMetic Life Sciences Main Business Overview
11.20.5 ProMetic Life Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Alpha-1 Lung Disease Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Augmentation Therapy
Table 3. Major Players of Cystic Fibrosis(CF)
Table 4. Major Players of Non-CF Bronchiectasis(NCFB)
Table 5. Major Players of Other
Table 6. Alpha-1 Lung Disease Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Alpha-1 Lung Disease Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
Table 9. Alpha-1 Lung Disease Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Alpha-1 Lung Disease Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
Table 12. Global Alpha-1 Lung Disease Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Alpha-1 Lung Disease Revenue Market Share by Player (2018-2023)
Table 14. Alpha-1 Lung Disease Key Players Head office and Products Offered
Table 15. Alpha-1 Lung Disease Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Alpha-1 Lung Disease Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Alpha-1 Lung Disease Market Size Market Share by Regions (2018-2023)
Table 20. Global Alpha-1 Lung Disease Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Alpha-1 Lung Disease Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Alpha-1 Lung Disease Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Alpha-1 Lung Disease Market Size Market Share by Country (2018-2023)
Table 24. Americas Alpha-1 Lung Disease Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
Table 26. Americas Alpha-1 Lung Disease Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
Table 28. APAC Alpha-1 Lung Disease Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Alpha-1 Lung Disease Market Size Market Share by Region (2018-2023)
Table 30. APAC Alpha-1 Lung Disease Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
Table 32. APAC Alpha-1 Lung Disease Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
Table 34. Europe Alpha-1 Lung Disease Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Alpha-1 Lung Disease Market Size Market Share by Country (2018-2023)
Table 36. Europe Alpha-1 Lung Disease Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
Table 38. Europe Alpha-1 Lung Disease Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Alpha-1 Lung Disease Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Alpha-1 Lung Disease Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Alpha-1 Lung Disease Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Alpha-1 Lung Disease
Table 47. Key Market Challenges & Risks of Alpha-1 Lung Disease
Table 48. Key Industry Trends of Alpha-1 Lung Disease
Table 49. Global Alpha-1 Lung Disease Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Alpha-1 Lung Disease Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Alpha-1 Lung Disease Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Alpha-1 Lung Disease Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Pfizer Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 54. Pfizer Alpha-1 Lung Disease Product Offered
Table 55. Pfizer Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. Baxter Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 59. Baxter Alpha-1 Lung Disease Product Offered
Table 60. Baxter Main Business
Table 61. Baxter Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Baxter Latest Developments
Table 63. AstraZeneca Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 64. AstraZeneca Alpha-1 Lung Disease Product Offered
Table 65. AstraZeneca Main Business
Table 66. AstraZeneca Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. AstraZeneca Latest Developments
Table 68. Grifols Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 69. Grifols Alpha-1 Lung Disease Product Offered
Table 70. Grifols Main Business
Table 71. Grifols Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Grifols Latest Developments
Table 73. Teva Pharmaceutical Industries Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 74. Teva Pharmaceutical Industries Alpha-1 Lung Disease Product Offered
Table 75. Teva Pharmaceutical Industries Main Business
Table 76. Teva Pharmaceutical Industries Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Teva Pharmaceutical Industries Latest Developments
Table 78. Boehringer Ingelheim Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 79. Boehringer Ingelheim Alpha-1 Lung Disease Product Offered
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Kamada Ltd Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 84. Kamada Ltd Alpha-1 Lung Disease Product Offered
Table 85. Kamada Ltd Main Business
Table 86. Kamada Ltd Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Kamada Ltd Latest Developments
Table 88. GlaxoSmithKline Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 89. GlaxoSmithKline Alpha-1 Lung Disease Product Offered
Table 90. GlaxoSmithKline Main Business
Table 91. GlaxoSmithKline Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. GlaxoSmithKline Latest Developments
Table 93. CSL Behring Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 94. CSL Behring Alpha-1 Lung Disease Product Offered
Table 95. CSL Behring Main Business
Table 96. CSL Behring Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. CSL Behring Latest Developments
Table 98. Takeda Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 99. Takeda Alpha-1 Lung Disease Product Offered
Table 100. Takeda Main Business
Table 101. Takeda Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Takeda Latest Developments
Table 103. LFB Biomedicaments Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 104. LFB Biomedicaments Alpha-1 Lung Disease Product Offered
Table 105. LFB Biomedicaments Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. LFB Biomedicaments Main Business
Table 107. LFB Biomedicaments Latest Developments
Table 108. Abeona Therapeutics Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 109. Abeona Therapeutics Alpha-1 Lung Disease Product Offered
Table 110. Abeona Therapeutics Main Business
Table 111. Abeona Therapeutics Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Abeona Therapeutics Latest Developments
Table 113. Biogen Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 114. Biogen Alpha-1 Lung Disease Product Offered
Table 115. Biogen Main Business
Table 116. Biogen Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Biogen Latest Developments
Table 118. Vertex Pharmaceuticals Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 119. Vertex Pharmaceuticals Alpha-1 Lung Disease Product Offered
Table 120. Vertex Pharmaceuticals Main Business
Table 121. Vertex Pharmaceuticals Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Vertex Pharmaceuticals Latest Developments
Table 123. Baxalta Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 124. Baxalta Alpha-1 Lung Disease Product Offered
Table 125. Baxalta Main Business
Table 126. Baxalta Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Baxalta Latest Developments
Table 128. Arrowhead Research Corporation Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 129. Arrowhead Research Corporation Alpha-1 Lung Disease Product Offered
Table 130. Arrowhead Research Corporation Main Business
Table 131. Arrowhead Research Corporation Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Arrowhead Research Corporation Latest Developments
Table 133. ProBioGen Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 134. ProBioGen Alpha-1 Lung Disease Product Offered
Table 135. ProBioGen Main Business
Table 136. ProBioGen Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. ProBioGen Latest Developments
Table 138. Chiesi Pharmaceuticals Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 139. Chiesi Pharmaceuticals Alpha-1 Lung Disease Product Offered
Table 140. Chiesi Pharmaceuticals Main Business
Table 141. Chiesi Pharmaceuticals Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 142. Chiesi Pharmaceuticals Latest Developments
Table 143. Kedrion Group Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 144. Kedrion Group Alpha-1 Lung Disease Product Offered
Table 145. Kedrion Group Main Business
Table 146. Kedrion Group Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 147. Kedrion Group Latest Developments
Table 148. ProMetic Life Sciences Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 149. ProMetic Life Sciences Alpha-1 Lung Disease Product Offered
Table 150. ProMetic Life Sciences Main Business
Table 151. ProMetic Life Sciences Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 152. ProMetic Life Sciences Latest Developments
Table 1. Alpha-1 Lung Disease Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Augmentation Therapy
Table 3. Major Players of Cystic Fibrosis(CF)
Table 4. Major Players of Non-CF Bronchiectasis(NCFB)
Table 5. Major Players of Other
Table 6. Alpha-1 Lung Disease Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Alpha-1 Lung Disease Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
Table 9. Alpha-1 Lung Disease Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Alpha-1 Lung Disease Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
Table 12. Global Alpha-1 Lung Disease Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Alpha-1 Lung Disease Revenue Market Share by Player (2018-2023)
Table 14. Alpha-1 Lung Disease Key Players Head office and Products Offered
Table 15. Alpha-1 Lung Disease Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Alpha-1 Lung Disease Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Alpha-1 Lung Disease Market Size Market Share by Regions (2018-2023)
Table 20. Global Alpha-1 Lung Disease Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Alpha-1 Lung Disease Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Alpha-1 Lung Disease Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Alpha-1 Lung Disease Market Size Market Share by Country (2018-2023)
Table 24. Americas Alpha-1 Lung Disease Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
Table 26. Americas Alpha-1 Lung Disease Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
Table 28. APAC Alpha-1 Lung Disease Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Alpha-1 Lung Disease Market Size Market Share by Region (2018-2023)
Table 30. APAC Alpha-1 Lung Disease Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
Table 32. APAC Alpha-1 Lung Disease Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
Table 34. Europe Alpha-1 Lung Disease Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Alpha-1 Lung Disease Market Size Market Share by Country (2018-2023)
Table 36. Europe Alpha-1 Lung Disease Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
Table 38. Europe Alpha-1 Lung Disease Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Alpha-1 Lung Disease Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Alpha-1 Lung Disease Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Alpha-1 Lung Disease Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Alpha-1 Lung Disease
Table 47. Key Market Challenges & Risks of Alpha-1 Lung Disease
Table 48. Key Industry Trends of Alpha-1 Lung Disease
Table 49. Global Alpha-1 Lung Disease Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Alpha-1 Lung Disease Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Alpha-1 Lung Disease Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Alpha-1 Lung Disease Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Pfizer Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 54. Pfizer Alpha-1 Lung Disease Product Offered
Table 55. Pfizer Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. Baxter Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 59. Baxter Alpha-1 Lung Disease Product Offered
Table 60. Baxter Main Business
Table 61. Baxter Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Baxter Latest Developments
Table 63. AstraZeneca Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 64. AstraZeneca Alpha-1 Lung Disease Product Offered
Table 65. AstraZeneca Main Business
Table 66. AstraZeneca Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. AstraZeneca Latest Developments
Table 68. Grifols Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 69. Grifols Alpha-1 Lung Disease Product Offered
Table 70. Grifols Main Business
Table 71. Grifols Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Grifols Latest Developments
Table 73. Teva Pharmaceutical Industries Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 74. Teva Pharmaceutical Industries Alpha-1 Lung Disease Product Offered
Table 75. Teva Pharmaceutical Industries Main Business
Table 76. Teva Pharmaceutical Industries Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Teva Pharmaceutical Industries Latest Developments
Table 78. Boehringer Ingelheim Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 79. Boehringer Ingelheim Alpha-1 Lung Disease Product Offered
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Kamada Ltd Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 84. Kamada Ltd Alpha-1 Lung Disease Product Offered
Table 85. Kamada Ltd Main Business
Table 86. Kamada Ltd Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Kamada Ltd Latest Developments
Table 88. GlaxoSmithKline Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 89. GlaxoSmithKline Alpha-1 Lung Disease Product Offered
Table 90. GlaxoSmithKline Main Business
Table 91. GlaxoSmithKline Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. GlaxoSmithKline Latest Developments
Table 93. CSL Behring Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 94. CSL Behring Alpha-1 Lung Disease Product Offered
Table 95. CSL Behring Main Business
Table 96. CSL Behring Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. CSL Behring Latest Developments
Table 98. Takeda Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 99. Takeda Alpha-1 Lung Disease Product Offered
Table 100. Takeda Main Business
Table 101. Takeda Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Takeda Latest Developments
Table 103. LFB Biomedicaments Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 104. LFB Biomedicaments Alpha-1 Lung Disease Product Offered
Table 105. LFB Biomedicaments Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. LFB Biomedicaments Main Business
Table 107. LFB Biomedicaments Latest Developments
Table 108. Abeona Therapeutics Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 109. Abeona Therapeutics Alpha-1 Lung Disease Product Offered
Table 110. Abeona Therapeutics Main Business
Table 111. Abeona Therapeutics Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Abeona Therapeutics Latest Developments
Table 113. Biogen Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 114. Biogen Alpha-1 Lung Disease Product Offered
Table 115. Biogen Main Business
Table 116. Biogen Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Biogen Latest Developments
Table 118. Vertex Pharmaceuticals Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 119. Vertex Pharmaceuticals Alpha-1 Lung Disease Product Offered
Table 120. Vertex Pharmaceuticals Main Business
Table 121. Vertex Pharmaceuticals Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Vertex Pharmaceuticals Latest Developments
Table 123. Baxalta Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 124. Baxalta Alpha-1 Lung Disease Product Offered
Table 125. Baxalta Main Business
Table 126. Baxalta Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Baxalta Latest Developments
Table 128. Arrowhead Research Corporation Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 129. Arrowhead Research Corporation Alpha-1 Lung Disease Product Offered
Table 130. Arrowhead Research Corporation Main Business
Table 131. Arrowhead Research Corporation Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Arrowhead Research Corporation Latest Developments
Table 133. ProBioGen Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 134. ProBioGen Alpha-1 Lung Disease Product Offered
Table 135. ProBioGen Main Business
Table 136. ProBioGen Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. ProBioGen Latest Developments
Table 138. Chiesi Pharmaceuticals Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 139. Chiesi Pharmaceuticals Alpha-1 Lung Disease Product Offered
Table 140. Chiesi Pharmaceuticals Main Business
Table 141. Chiesi Pharmaceuticals Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 142. Chiesi Pharmaceuticals Latest Developments
Table 143. Kedrion Group Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 144. Kedrion Group Alpha-1 Lung Disease Product Offered
Table 145. Kedrion Group Main Business
Table 146. Kedrion Group Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 147. Kedrion Group Latest Developments
Table 148. ProMetic Life Sciences Details, Company Type, Alpha-1 Lung Disease Area Served and Its Competitors
Table 149. ProMetic Life Sciences Alpha-1 Lung Disease Product Offered
Table 150. ProMetic Life Sciences Main Business
Table 151. ProMetic Life Sciences Alpha-1 Lung Disease Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 152. ProMetic Life Sciences Latest Developments
LIST OF FIGURES
Figure 1. Alpha-1 Lung Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Alpha-1 Lung Disease Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Alpha-1 Lung Disease Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Alpha-1 Lung Disease Sales Market Share by Country/Region (2022)
Figure 8. Alpha-1 Lung Disease Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Alpha-1 Lung Disease Market Size Market Share by Type in 2022
Figure 10. Alpha-1 Lung Disease in Hospitals
Figure 11. Global Alpha-1 Lung Disease Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Alpha-1 Lung Disease in Specialty Clinics
Figure 13. Global Alpha-1 Lung Disease Market: Specialty Clinics (2018-2023) & ($ Millions)
Figure 14. Alpha-1 Lung Disease in Pharmacies
Figure 15. Global Alpha-1 Lung Disease Market: Pharmacies (2018-2023) & ($ Millions)
Figure 16. Alpha-1 Lung Disease in Others
Figure 17. Global Alpha-1 Lung Disease Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Alpha-1 Lung Disease Market Size Market Share by Application in 2022
Figure 19. Global Alpha-1 Lung Disease Revenue Market Share by Player in 2022
Figure 20. Global Alpha-1 Lung Disease Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Alpha-1 Lung Disease Market Size 2018-2023 ($ Millions)
Figure 22. APAC Alpha-1 Lung Disease Market Size 2018-2023 ($ Millions)
Figure 23. Europe Alpha-1 Lung Disease Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Alpha-1 Lung Disease Market Size 2018-2023 ($ Millions)
Figure 25. Americas Alpha-1 Lung Disease Value Market Share by Country in 2022
Figure 26. United States Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Alpha-1 Lung Disease Market Size Market Share by Region in 2022
Figure 31. APAC Alpha-1 Lung Disease Market Size Market Share by Type in 2022
Figure 32. APAC Alpha-1 Lung Disease Market Size Market Share by Application in 2022
Figure 33. China Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Alpha-1 Lung Disease Market Size Market Share by Country in 2022
Figure 40. Europe Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
Figure 41. Europe Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
Figure 42. Germany Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 56. APAC Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 57. Europe Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 59. United States Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 60. Canada Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 63. China Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 64. Japan Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 65. Korea Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 67. India Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 68. Australia Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 69. Germany Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 70. France Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 71. UK Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 72. Italy Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 73. Russia Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 74. Spain Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 77. Israel Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 80. Global Alpha-1 Lung Disease Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Alpha-1 Lung Disease Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Alpha-1 Lung Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Alpha-1 Lung Disease Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Alpha-1 Lung Disease Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Alpha-1 Lung Disease Sales Market Share by Country/Region (2022)
Figure 8. Alpha-1 Lung Disease Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Alpha-1 Lung Disease Market Size Market Share by Type in 2022
Figure 10. Alpha-1 Lung Disease in Hospitals
Figure 11. Global Alpha-1 Lung Disease Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Alpha-1 Lung Disease in Specialty Clinics
Figure 13. Global Alpha-1 Lung Disease Market: Specialty Clinics (2018-2023) & ($ Millions)
Figure 14. Alpha-1 Lung Disease in Pharmacies
Figure 15. Global Alpha-1 Lung Disease Market: Pharmacies (2018-2023) & ($ Millions)
Figure 16. Alpha-1 Lung Disease in Others
Figure 17. Global Alpha-1 Lung Disease Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Alpha-1 Lung Disease Market Size Market Share by Application in 2022
Figure 19. Global Alpha-1 Lung Disease Revenue Market Share by Player in 2022
Figure 20. Global Alpha-1 Lung Disease Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Alpha-1 Lung Disease Market Size 2018-2023 ($ Millions)
Figure 22. APAC Alpha-1 Lung Disease Market Size 2018-2023 ($ Millions)
Figure 23. Europe Alpha-1 Lung Disease Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Alpha-1 Lung Disease Market Size 2018-2023 ($ Millions)
Figure 25. Americas Alpha-1 Lung Disease Value Market Share by Country in 2022
Figure 26. United States Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Alpha-1 Lung Disease Market Size Market Share by Region in 2022
Figure 31. APAC Alpha-1 Lung Disease Market Size Market Share by Type in 2022
Figure 32. APAC Alpha-1 Lung Disease Market Size Market Share by Application in 2022
Figure 33. China Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Alpha-1 Lung Disease Market Size Market Share by Country in 2022
Figure 40. Europe Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
Figure 41. Europe Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
Figure 42. Germany Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Alpha-1 Lung Disease Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Alpha-1 Lung Disease Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 56. APAC Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 57. Europe Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 59. United States Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 60. Canada Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 63. China Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 64. Japan Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 65. Korea Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 67. India Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 68. Australia Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 69. Germany Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 70. France Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 71. UK Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 72. Italy Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 73. Russia Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 74. Spain Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 77. Israel Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Alpha-1 Lung Disease Market Size 2024-2029 ($ Millions)
Figure 80. Global Alpha-1 Lung Disease Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Alpha-1 Lung Disease Market Size Market Share Forecast by Application (2024-2029)
